During the past decade, MBAL "Tokuda Bolnitsa", Otdelenie po nevrologiya conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "MBAL "Tokuda Bolnitsa", Otdelenie po nevrologiya" are "Ischemic Stroke" (1 trials) and "Post Herpetic Neuralgia" (1 trials). Many other conditions were trialed in "MBAL "Tokuda Bolnitsa", Otdelenie po nevrologiya" in a lesser frequency.

Most popular intervention types in "MBAL "Tokuda Bolnitsa", Otdelenie po nevrologiya" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "PF-03049423" (1 trials), "Placebo" (1 trials), "Pregabalin" (1 trials) and "placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "MBAL "Tokuda Bolnitsa", Otdelenie po nevrologiya" are 2 trials for "All" genders.

Currently, there are NaN active trials in "MBAL "Tokuda Bolnitsa", Otdelenie po nevrologiya". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in MBAL "Tokuda Bolnitsa", Otdelenie po nevrologiya, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in MBAL "Tokuda Bolnitsa", Otdelenie po nevrologiya, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".